advertisement
Lee D 10
Showing records 1 to 10 | Display all abstracts from Lee D95633 Proteomic analysis of aqueous humor in canine primary angle-closure glaucoma in American Cocker Spaniel dogs
Yun S
Veterinary Ophthalmology 2021; 24: 520-532
95894 The effectiveness and safety profile of netarsudil 0.02% in glaucoma treatment: real-world 6-month outcomes
Shiuey EJ; Mehran NA
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 260: 967-974
95633 Proteomic analysis of aqueous humor in canine primary angle-closure glaucoma in American Cocker Spaniel dogs
Lee D
Veterinary Ophthalmology 2021; 24: 520-532
95894 The effectiveness and safety profile of netarsudil 0.02% in glaucoma treatment: real-world 6-month outcomes
Ustaoglu M
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 260: 967-974
95633 Proteomic analysis of aqueous humor in canine primary angle-closure glaucoma in American Cocker Spaniel dogs
Kang S; Kim DW
Veterinary Ophthalmology 2021; 24: 520-532
95894 The effectiveness and safety profile of netarsudil 0.02% in glaucoma treatment: real-world 6-month outcomes
Zhang Q; Razeghinejad R
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 260: 967-974
95633 Proteomic analysis of aqueous humor in canine primary angle-closure glaucoma in American Cocker Spaniel dogs
Kim Y; Cho JY
Veterinary Ophthalmology 2021; 24: 520-532
95894 The effectiveness and safety profile of netarsudil 0.02% in glaucoma treatment: real-world 6-month outcomes
Shukla AG; Shukla AG; Kolomeyer NN
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 260: 967-974
95633 Proteomic analysis of aqueous humor in canine primary angle-closure glaucoma in American Cocker Spaniel dogs
Seo K
Veterinary Ophthalmology 2021; 24: 520-532
95894 The effectiveness and safety profile of netarsudil 0.02% in glaucoma treatment: real-world 6-month outcomes
Kolomeyer NN; Myers JS; Lee D
Graefe's Archive for Clinical and Experimental Ophthalmology 2022; 260: 967-974
